Skip to content
Thomson Reuters
Corporate Governance

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Reuters Staff

30 Oct 2017

WASHINGTON (Reuters) – Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

The allegations relate to billing for ineligible patients and inflated levels of care, the department said in a statement. Vitas Hospice Services is the largest U.S. for-profit hospice chain, it said.

Reporting by Eric Walsh; Editing by Mohammad Zargham
Our Standards:The Thomson Reuters Trust Principles.
Release: More than 20 Global Business and Civil Society Leaders Urge European Union to Step Up Its Ambition on Climate In U-turn, Exxon, Chevron to join industry climate initiative Electric cars cast growing shadow on profits EXECUTIVE PERSPECTIVE: Driving the Circular Economy with Vision and Technology EXECUTIVE PERSPECTIVE: An Example of Sector Leadership when the Climate is Changing Release: Challenges in Africa’s Innovative Ecosystem China’s solar giant GCL to make electric car move in new ‘eco-town’ When bits meet bites: Kenya’s farm-to-fork online delivery cuts waste, boosts earnings Inside Tesla’s troubled New York solar factory DowDuPont ‘defers’ field trials to seek sale of GM corn seed in India